Participating entities
IrsiCaixa AIDS Research Institute
The emergence of drug resistance and the need for simplified treatment and management options for HIV patients with co-infections (e.g., HCV) treated over the long term is an obstacle to effective reduction in AIDS incidence and prevalence. We have created an interdisciplinary team to design, develop and evaluate antiviral strategies, whose members have identified, optimized and patented one antiviral agent generated in our previous project.